Skip to main content
Signal8

Bausch Health Companies Inc. (BHC)

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - Specialty & Generic

Bausch Health Companies Inc. logo

Bausch Health Companies Inc.

NYSE:BHCHealthcare
+3.07%$8.73
CLOSED
AH$8.73+0.00%vs close
Mkt Cap$3.27B
EV-
Float264.25M
O/S374.27M
VOL7.06M sh
$ Vol$61.5M
RVOL1.44×
Inst Own61.2%
SI2.8%
Net Cash/Sh-
Dilution
Bausch Health Companies Inc. logoNYSE:BHCClosed$8.73+3.07%
Historical Data
DateOpenHighLowCloseVolume
Nov 18, 20268.438.858.418.737,062,107
Nov 17, 20268.398.488.218.472,702,689
Nov 16, 20268.348.578.348.423,819,039
Nov 13, 20268.258.408.188.352,340,417
Nov 12, 20268.368.438.248.252,350,370
Nov 11, 20268.298.468.208.352,401,051
Nov 10, 20268.398.398.158.292,450,866
Nov 9, 20268.198.568.198.403,952,086
Nov 6, 20267.868.207.868.183,067,557
Nov 5, 20268.348.387.967.963,344,721
Nov 4, 20268.288.468.228.343,529,976
Nov 3, 20267.968.187.878.143,422,162
Nov 2, 20268.218.357.968.024,943,345
Oct 30, 20268.939.048.188.208,868,424
Oct 29, 20267.669.047.588.9133,781,852
Oct 28, 20266.296.976.256.928,073,976
Oct 27, 20266.376.376.226.311,562,813
Oct 26, 20266.536.556.276.352,401,570
Oct 23, 20266.446.496.206.442,427,285
Oct 22, 20266.436.506.416.491,196,581
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$8.50-2.6%
Low $8High $9
Ratings Distribution
BUY
19
HOLD
15
SELL
4
TOTAL38
Insider Trades
InsiderTypeShares
LEUNG SANDRA profile photoLEUNG SANDRAGrant/Award5.8K
WECHSLER AMY B profile photoWECHSLER AMY BGrant/Award1.2K
Paulson John profile photoPaulson JohnGrant/Award10.7K
Lenar Aimee J. profile photoLenar Aimee J.Sale36.8K
Lenar Aimee J. profile photoLenar Aimee J.Automatic Sell5.3K
Lenar Aimee J. profile photoLenar Aimee J.Automatic Sell23.4K
Shareholders
61.2%
Institutional
(234)
1.8%
Insiderⓘ
(18)
0.0%
5%+ Owners
(0)
37.0%
Unattributed (incl. retail)ⓘ
Institutional61.2%
Insider1.8%
Unattributed (incl. retail)37.0%
Sources: 13F, Form 4, 13D/13GO/S: 374.3M · as of 23 Oct 2026 · SEC cover page
Insiders & Institutional Holders
About

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies.

Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S.

The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018.

Its corporate headquarters are located in Laval, Canada.

Key Metrics
Market Cap$3.27B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership61.23%

based on 374.27M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNYSE
CountryCACA
IPO DateMar 29, 1994
Shares Outstanding374.27M
Authorized Shares
Float264.25M
52-Week Range
$4.33$8.00
$8.73(100th percentile)
Volume
Average Daily Volume4.90M
7.06M today vs 4.90M avg(+44%)

30d Avg

4.90M

60d Avg

3.39M

90d Avg

3.17M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Bausch Health Companies Inc. (NYSE: BHC) traded at $8.73 on Nov 18, 2026, up 3.07% from the previous close of $8.47. The company is in the Healthcare sector (Drug Manufacturers - Specialty & Generic).